Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients.
about
Anti-inflammatory and immunosuppressive drugs and reproductionPediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.Is newer safer? Adverse events associated with first-line therapies for ANCA-associated vasculitis and lupus nephritis.Initiation of puberty in mice following decellularized ovary transplant.Managing pregnancy in inflammatory rheumatological diseasesNonmalignant diseases and treatments associated with primary ovarian failure: an expanded role for fertility preservation.Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's).Myeloperoxidase Peptide-Based Nasal Tolerance in Experimental ANCA-Associated GN.Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: Results from a case control study and literature review.Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitisAvoidance of Harm From Treatment for ANCA-Associated Vasculitis.Relapsing granulomatosis with polyangiitis with severe lung and upper respiratory tract involvement successfully treated with rituximab.Efficacy and safety of cyclophosphamide treatment in severe juvenile dermatomyositis shown by marginal structural modelling.Cyclophosphamide Pulse Therapy in Severe Refractory Crohn's Disease: A Retrospective Multicenter Case Series
P2860
Q28218219-DB2CB34E-DB9D-4F6A-A68A-F0568DE99B52Q33723511-9EF12CEE-7ECB-484A-A4F5-C80B4514BC5BQ33805271-0D24F085-E2E9-464C-BD4A-5D5F950ECE2BQ34124711-C1FF51EB-93D1-4FBE-9FCD-896B37A5987AQ35148516-1E0A4223-9DF3-4356-BA20-F7CECCB36E69Q35169341-41519CE8-5762-47E0-9E35-89DDEAE8A8CCQ35267073-79AD22FD-C2B5-4868-81FC-8ACBFA3F1EF8Q35835278-26E25382-38B1-407A-B9BE-B98486398A86Q36514958-7FBAB6B3-614F-43E8-AE07-C33220866FC0Q37063971-57788306-5DC4-4578-A665-48A0DC568081Q37640836-FA416527-3FAF-4897-80F5-5FC6CB2D642CQ47105115-30514596-B79A-409F-82DF-5E79BC025E7AQ47134404-E348B9F6-0C26-488B-95F5-24C5C63147CEQ49998617-1962A6B4-9561-4D58-B976-AFAD6A22D190Q56968600-E3D29488-48B7-4721-AD17-A03125A9C39C
P2860
Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Risk of ovarian failure and fe ...... amide. A study in 84 patients.
@ast
Risk of ovarian failure and fe ...... amide. A study in 84 patients.
@en
Risk of ovarian failure and fe ...... amide. A study in 84 patients.
@nl
type
label
Risk of ovarian failure and fe ...... amide. A study in 84 patients.
@ast
Risk of ovarian failure and fe ...... amide. A study in 84 patients.
@en
Risk of ovarian failure and fe ...... amide. A study in 84 patients.
@nl
prefLabel
Risk of ovarian failure and fe ...... amide. A study in 84 patients.
@ast
Risk of ovarian failure and fe ...... amide. A study in 84 patients.
@en
Risk of ovarian failure and fe ...... amide. A study in 84 patients.
@nl
P2093
P1476
Risk of ovarian failure and fe ...... hamide. A study in 84 patients
@en
P2093
Abdallah Sbai
Bertrand Wechsler
Du Le thi Huong
Nathalie Costedoat
Pierre Duhaut
P304
P407
P577
2002-12-01T00:00:00Z